27-Sep-2020 | Facts and Factors
Findings from Facts and Factors has authored “Plasma Therapy Market Type (Pure PRP, Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous, Allogenic), Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Others), End User (Hospitals & Clinics, Research Institutions): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026” States that the global Plasma Therapy market in 2019 was approximately USD 200 million. The market is expected to grow above a CAGR of 13.9% and is anticipated to reach over USD 495 million by 2026.
Blood plasma includes delicate tissue mending platelets, autologous platelets, and cytokines. It stays a standard technique comprehensively utilized in strengths of dentistry, orthopedics, and dermatology. Plasma treatment is normally utilized in wound recuperating, facial restoration, and androgenetic alopecia. Plasma is centered around the physiological incentive up to three to multiple times and afterward immunized into the tissues.
The developing pervasiveness of the COVID-19 pandemic has positive effect on the worldwide Plasma Therapy market. Noteworthy budgetary speculations including innovations and their little circulation are probably going to help the development of the market. Also, the expanding utilization of Plasma Therapy in various areas of end-clients across developing nations is a part that invigorates market development. Nonetheless, high capital expense and inflexible administrative guidelines are the key elements limiting the development of the segment.
Browse the full “Plasma Therapy Market Type (Pure PRP, Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous, Allogenic), Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Others), End User (Hospitals & Clinics, Research Institutions): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026” https://www.fnfresearch.com/therapeutic-drug-monitoring-market-by-product-consumables-and-1274
The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Plasma Therapy industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.
On the basis of type, the global plasma therapy market is bifurcated into platelet-rich fibrin, pure PRP, leukocyte-rich fibrin, and leucocyte-rich PRP. The pure PRP section is assessed to represent the biggest portion of the worldwide market in 2019. One of the hugest elements driving the development of this market incorporates the successful aftereffects of pure PRP treatment. Nonetheless, absence of repayment approaches and changing costs of plasma treatment are thwarting the development of the market.
On the basis of source, the market is segmented into allogenic and autologous. The autologous portion is assessed to represent the biggest portion of the worldwide market in 2019. Attention to plasma treatment and its acknowledgment as a reasonable solution for recuperating of bones and different tissues are driving the development of the autologous source fragment of the market.
On application basis, the global plasma therapy market is bifurcated into orthopedics, dental, dermatology, nerve injury, cardiac muscle injury, and others. The dermatology section is relied upon to develop at the most elevated CAGR from 2019 to 2026, attributable to the expanding number of dermatological issues.
The end user segment is classified into research institutions and hospitals & clinics. The clinics and centers portion is assessed to represent the biggest portion of the worldwide market in 2019. This huge share is principally credited to ascend in medicinal services use and increment in the utilization of PRP items in emergency clinics.
The world market is bifurcated as North America, Latin America, APAC, Europe, and the MEA region. North America is projected to progressively rule the global market because of the developing rise of innovatively progressed advancements in the region. This development is because of an expansion in purchaser comprehension of the utilization of cutting edge medicinal services in the zone. North America is a very entrenched area regarding clinical information and the utilization of ADCs and makes up the greater part of the market. However, Asia Pacific is expected to spread at a high CAGR throughout the projected period due to the flare-up of Covid-19 in Wuhan Province in China and far and large in neighbouring countries.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 200 Million |
Projected Market Size in 2026 |
USD 495 Million |
CAGR Growth Rate |
13.9% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
Takeda Pharmaceutical Company ltd, Arthrex, Inc., BioLife Plasma Services, Bio Products Laboratory Ltd., Cambryn Biologics LLC, CSL Ltd., Biotest AG, China Biologic Products Holdings, Inc., DePuy Synthes Companies, Kedrion S.p.A, Grifols International S.A., LFB , Regen Lab USA LLC, Octapharma, Stryker, and Terumo BCT, Inc., and Others |
Key Segment |
By Type, Source, Application, End User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs.Explore purchase options |
Some of the leading players in the global market include
Takeda Pharmaceutical Company ltd, Arthrex, Inc., BioLife Plasma Services, Bio Products Laboratory Ltd., Cambryn Biologics LLC, CSL Ltd., Biotest AG, China Biologic Products Holdings, Inc., DePuy Synthes Companies, Kedrion S.p.A, Grifols International S.A., LFB , Regen Lab USA LLC, Octapharma, Stryker, and Terumo BCT, Inc.
This report segments the Plasma Therapy market as follows:
By Type Segment Analysis
- Pure PRP
- Leucocyte-rich PRP
- Pure Platelet-rich Fibrin (PRF)
- Leukocyte-rich Fibrin (L-PRF)
By Source Segment Analysis
By Application Segment Analysis
- Orthopedics
- Arthritis
- Chronic Tendinitis
- Bone Repair & Regeneration
- Dermatology
- Androgenic Alopecia
- Plastic Surgery
- Dental
- Cardiac Muscle Injury
- Nerve Injury
- Others
By End User Segment Analysis
- Hospitals & Clinics
- Research Institutions
By Regional Segment Analysis
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
